Prof. Percy P. Lee

David Geffen School of Medicine at UCLA

UCLA Jonsson Comprehensive Cancer Center

Department of Radiation Oncology, USA

Email: [email protected]

Qualifications

2003 M.D., Harvard Medical School

1998 B.Sc., Johns Hopkins University

Publications (selected )

1. Howard N, Schwer A L, Szeja S, et al. Evaluating Outcomes in NSCLC Patients Receiving Amivantamab and Intracranial Radiation[J]. International Journal of Radiation Oncology, Biology, Physics, 2025, 123(1): e165-e166.
2. Ladbury C, Sidiqi B, Cantrell N, et al. Stereotactic Body Radiation Therapy for Primary Lung Cancer and Metastases: A Case-Based Discussion on Challenging Cases[J]. Practical Radiation Oncology, 2025, 15(3): 262-276.
3. Soulsby W D, Olveda R, He J, et al. Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study[J]. Arthritis Care & Research, 2025, 77(1): 38-49.
4. Steinfort D P, Kothari G, Wallace N, et al. Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial[J]. The Lancet Respiratory Medicine, 2024, 12(6): 467-475. Steinfort D P, Kothari G, Wallace N, et al. Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial[J]. The Lancet Respiratory Medicine, 2024, 12(6): 467-475.
5. Chuong M D, Lee P, Low D A, et al. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study[J]. Radiotherapy and oncology, 2024, 191: 110064.
6. Parikh P J, Lee P, Low D A, et al. A multi-institutional phase 2 trial of ablative 5-fraction stereotactic magnetic resonance-guided on-table adaptive radiation therapy for borderline resectable and locally advanced pancreatic cancer[J]. International Journal of Radiation Oncology* Biology* Physics, 2023, 117(4): 799-808. Saad M B, Hong L, Aminu M, et al. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study[J]. The Lancet Digital Health, 2023, 5(7): e404-e420.
7. Jing W, Xu T, Wu L, et al. Severe radiation-induced lymphopenia attenuates the benefit of durvalumab after concurrent chemoradiotherapy for NSCLC[J]. JTO Clinical and Research Reports, 2022, 3(9): 100391.
8. Keall P J, Glide-Hurst C K, Cao M, et al. ICRU REPORT 97: MRI-guided radiation therapy using MRI-linear accelerators[J]. Journal of the ICRU, 2022, 22(1): 1-100.
9. Chang J Y, Mehran R J, Feng L, et al. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery[J]. The Lancet Oncology, 2021, 22(10): 1448-1457.
10. Glide-Hurst C K, Lee P, Yock A D, et al. Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART review from NRG oncology[J]. International Journal of Radiation Oncology* Biology* Physics, 2021, 109(4): 1054-1075.
11. Wang X, Palaskas N L, Yusuf S W, et al. Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer[J]. Journal of Thoracic Oncology, 2020, 15(10): 1682-1690.
12. Ng S S W, Ning M S, Lee P, et al. Single-fraction stereotactic body radiation therapy: a paradigm during the coronavirus disease 2019 (COVID-19) pandemic and beyond?[J]. Advances in radiation oncology, 2020, 5(4): 761-773.
13. Hall W A, Paulson E S, van der Heide U A, et al. The transformation of radiation oncology using real-time magnetic resonance guidance: A review[J]. European Journal of Cancer, 2019, 122: 42-52.
14. Rudra S, Jiang N, Rosenberg S A, et al. Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer[J]. Cancer medicine, 2019, 8(5): 2123-2132.
15. Rosenberg S A, Henke L E, Shaverdian N, et al. A multi-institutional experience of MR-guided liver stereotactic body radiation therapy[J]. Advances in radiation oncology, 2019, 4(1): 142-149.
16. Tyran M, Jiang N, Cao M, et al. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy[J]. Radiotherapy and Oncology, 2018, 129(2): 319-325.
17. Formenti S C, Lee P, Adams S, et al. Focal irradiation and systemic TGFβ blockade in metastatic breast cancer[J]. Clinical Cancer Research, 2018, 24(11): 2493-2504.
18. Thomas D H, Santhanam A, Kishan A U, et al. Initial clinical observations of intra-and interfractional motion variation in MR-guided lung SBRT[J]. The British journal of radiology, 2018, 91(1083): 20170522.
19. Rudra S, Jiang N, Rosenberg S A, et al. High dose adaptive MRI guided radiation therapy improves overall survival of inoperable pancreatic cancer[J]. International Journal of Radiation Oncology, Biology, Physics, 2017, 99(2): E184.
20. Lamb J, Cao M, Kishan A, et al. Online adaptive radiation therapy: implementation of a new process of care[J]. Cureus, 2017, 9(8).
21. Shaverdian N, Lisberg A E, Bornazyan K, et al. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial[J]. The lancet oncology, 2017, 18(7): 895-903.

Profile Details

https://www.uclahealth.org/departments/radonc

https://www.researchgate.net/profile/Percy-Lee

https://scholar.google.com/citations?user=l0fch9kAAAAJ&hl=en         

WoS ResearcherID: FHV-7212-2022